Knight Therapeutics (TSX:GUD) Ending Cash Position : C$58.8 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Knight Therapeutics Ending Cash Position?

Knight Therapeutics's Ending Cash Position for the quarter that ended in Dec. 2023 was C$58.8 Mil.

Knight Therapeutics's quarterly Ending Cash Position increased from Jun. 2023 (C$37.8 Mil) to Sep. 2023 (C$77.4 Mil) but then declined from Sep. 2023 (C$77.4 Mil) to Dec. 2023 (C$58.8 Mil).

Knight Therapeutics's annual Ending Cash Position declined from Dec. 2021 (C$86.0 Mil) to Dec. 2022 (C$71.7 Mil) and declined from Dec. 2022 (C$71.7 Mil) to Dec. 2023 (C$58.8 Mil).

Knight Therapeutics Ending Cash Position Historical Data

The historical data trend for Knight Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Knight Therapeutics Ending Cash Position Chart

Knight Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

174.27

229.59

85.96

71.68

58.76

Knight Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															71.68	56.22	37.84	77.42	58.76

Knight Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Knight Therapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	71.679	+	-12.918
	=	58.8

Knight Therapeutics's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	77.418	+	-18.657
	=	58.8

Knight Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Knight Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Knight Therapeutics (TSX:GUD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Knight Therapeutics Inc (TSX:GUD) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

KHTRF:USA

Address

3400 De Maisonneuve West, Suite 1055, Montreal, QC, CAN, H3Z 3B8

Website

https://www.gud-knight.com

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Ltin America and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.

Executives

Sime Armoyan

10% Security Holder

Knight Therapeutics (TSX:GUD) Headlines

No Headlines